ANIK
Anika Therapeutics Inc.

639
Loading...
Loading...
News
all
press releases
Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?
The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·14d ago
News Placeholder
More News
News Placeholder
Anika (ANIK) Upgraded to Buy: Here's What You Should Know
Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·23d ago
News Placeholder
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
uniQure (QURE) delivered earnings and revenue surprises of +22.47% and -26.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?
Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·2mo ago
News Placeholder
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates
chainwire·4mo ago
News Placeholder
Retail Investors Remain Cautious After Anika’s Q3 Earnings Misses Estimates
Barrington analyst Michael Petusky has cut the firm’s price target to $25 from $37
Stocktwits·10mo ago
News Placeholder
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics PR Newswire WEST BRIDGEWATER, Mass...
PR Newswire·11mo ago
News Placeholder
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
Latest Ratings for ANIK DateFirmActionFromTo Mar 2022Stephens & Co.DowngradesOverweightEqual-Weight Nov 2021Stephens & Co.Initiates Coverage OnOverweight Jul 2021UBSInitiates Coverage OnNeutral...
Benzinga·1y ago
News Placeholder
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Globe Newswire·1y ago

Latest ANIK News

View

Advertisement. Remove ads.

Advertisement. Remove ads.